2m 2m 2m 2m 2m 2m 2m
ORGANGNSS HLDG-A (ORGO)
NASDAQ
$1.50+$0.01 (+0.81%)
Price as of Sep 11, 2026 7:50 PM EDT- $191.7MMarket Cap
- -69.78%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ORGANGNSS HLDG-A (ORGO)
$1.50+$0.01 (+0.81%)
ORGO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.49 | ||
Change | -$0.04 (-2.61%) | ||
Open | $1.56 | ||
High | $1.56 | ||
Low | $1.47 | ||
Previous Close | $1.53 | ||
Volume | 844,153 | ||
30-Day Average Volume | 694,158 | ||
1-Week Change | -12.87% | ||
1-Month Change | -21.16% | ||
1-Year Change | -69.78% | ||
3-Year Change | -42.91% | ||
5-Year Change | -91.09% | ||
Fundamentals | |||
Shares Outstanding | 128.7M | ||
Total Assets | $406.4M | ||
Market Cap | $191.7M | ||
Enterprise Value | $195.6M | ||
Period: QTR TTM FY | |||
Revenue | $42.8M | ||
Net Income | -$96.3M | ||
Free Cash Flow | -$32.8M | ||
EBIT | -$50.9M | ||
EBITDA | -$50.4M | ||
Net Working Capital | $143.3M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue